{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:03:35Z","timestamp":1790553815349,"version":"4.1.0"},"reference-count":46,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,2,28]]},"DOI":"10.18632\/oncotarget.13264","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T13:33:23Z","timestamp":1478784803000},"page":"14502-14515","source":"Crossref","is-referenced-by-count":51,"title":["KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species"],"prefix":"10.18632","volume":"8","author":[{"given":"Georgios","family":"Pampalakis","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasia-Samantha","family":"Sykioti","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, Biomedical Research Foundation, Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Methodios","family":"Ximerakis","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, Biomedical Research Foundation, Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Stefanakou-Kalakou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Melki","sequence":"additional","affiliation":[{"name":"Paris-Saclay Institute of Neuroscience, Centre National de la Recherche Scientifique, Gif-Sur-Yvette, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Vekrellis","sequence":"additional","affiliation":[{"name":"Center for Neurosciences, Biomedical Research Foundation, Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Sotiropoulou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Athens, Greece"},{"name":"Center for Neurosciences, Biomedical Research Foundation, Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,10]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","article-title":"Pathological roles of alpha-synuclein in neurological disorders","volume":"10","author":"Stefanis","year":"2011","journal-title":"Lancet Neurol"},{"key":"2","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Vekrellis","year":"2010","journal-title":"J Neurosci"},{"key":"3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Kopito","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Lee","year":"2012","journal-title":"Science"},{"key":"5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.expneurol.2008.10.010","article-title":"Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases","volume":"215","author":"Lorenzl","year":"2009","journal-title":"Exp Neurol"},{"key":"6","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1074\/jbc.M503341200","article-title":"Proteolytic cleavage of extracellular secreted a-synuclein via matrix metalloproteinases","volume":"280","author":"Chung","year":"2005","journal-title":"J Biol Chem"},{"key":"7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/exnr.2002.8019","article-title":"Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease","volume":"178","author":"Beal","year":"2002","journal-title":"Exp Neurol"},{"key":"8","doi-asserted-by":"crossref","first-page":"24862","DOI":"10.1074\/jbc.M112.348128","article-title":"Proteolytic cleavage of extracellular alpha-synuclein by plasmin: implications for Parkinson disease","volume":"287","author":"Park","year":"2012","journal-title":"J Biol Chem"},{"key":"9","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","article-title":"Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation","volume":"97","author":"Crowther","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-5793(98)01146-6","article-title":"Synthetic filaments assembled from C-terminally truncated alpha-synuclein","volume":"436","author":"Goedert","year":"1998","journal-title":"FEBS Lett"},{"key":"11","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Lee","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"12","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/hmg\/ddg283","article-title":"Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies","volume":"12","author":"Nukina","year":"2003","journal-title":"Hum Mol Genet"},{"key":"13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neures.2010.04.008","article-title":"Extracellular neurosin degrades \u03b1-synuclein in cultured cells","volume":"67","author":"Tokuda","year":"2010","journal-title":"Neurosci Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2008.02.057","article-title":"Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro","volume":"436","author":"Mizuno","year":"2008","journal-title":"Neurosci Lett"},{"key":"15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03401646","article-title":"A novel protease homolog differentially expressed in breast and ovarian cancer","volume":"2","author":"Sager","year":"1996","journal-title":"Mol Med"},{"key":"16","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1523\/JNEUROSCI.17-21-08156.1997","article-title":"Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury","volume":"17","author":"Isackson","year":"1997","journal-title":"J Neurosci"},{"key":"17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0009-9120(00)00145-4","article-title":"Immunofluorometric assay of human kallikrein 6 (zyme\/protease M\/neurosin) and preliminary clinical applications","volume":"33","author":"Sotiropoulou","year":"2000","journal-title":"Clin Biochem"},{"key":"18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pmic.200600756","article-title":"A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry","volume":"7","author":"Zhang","year":"2007","journal-title":"Proteomics"},{"key":"19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/pmic.200400934","article-title":"Proteomics analysis of prefractionated human lumbar cerebrospinal fluid","volume":"5","author":"Desiderio","year":"2005","journal-title":"Proteomics"},{"key":"20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s40478-014-0164-0","article-title":"Accumulation of a-synuclein in dementia with Lewy bodies is associated with decline in the a-synuclein-degrading enzymes kallikrein-6 and calpain-1","volume":"2","author":"Love","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/mt.2012.66","article-title":"Lentivirus mediated delivery of neurosin promotes clearance of wild-type alpha-synuclein and reduces the pathology in the alpha-synuclein model of LBD","volume":"21","author":"Masliah","year":"2013","journal-title":"Mol Ther"},{"key":"22","doi-asserted-by":"crossref","first-page":"e53250","DOI":"10.1371\/journal.pone.0053250","article-title":"Low CSF levels of both a-synuclein and the a-synuclein cleaving enzyme neurosin in patients with synucleinopathy","volume":"8","author":"Nielsen","year":"2013","journal-title":"PLoS One"},{"key":"23","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1096\/fj.13-245852","article-title":"Resistance of naturally secreted a-synuclein to proteolysis","volume":"28","author":"Vekrellis","year":"2014","journal-title":"FASEB J"},{"key":"24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/bj3080645","article-title":"Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate","volume":"308","author":"Nagase","year":"1995","journal-title":"Biochem J"},{"key":"25","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1471-4159.2009.06054.x","article-title":"Inducible over-expression of wild-type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death","volume":"109","author":"Stefanis","year":"2009","journal-title":"J Neurochem"},{"key":"26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2006.05.024","article-title":"Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer","volume":"10","author":"Yao","year":"2006","journal-title":"Cancer Cell"},{"key":"27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0076-6879(95)48030-7","article-title":"Gelatinases A and B","volume":"248","author":"Crabbe","year":"1995","journal-title":"Methods Enzymol"},{"key":"28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2144\/05381RV01","article-title":"Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors","volume":"38","author":"Von den Hoff","year":"2005","journal-title":"Biotechniques"},{"key":"29","first-page":"517","article-title":"Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation\/inactivation","volume":"385","author":"Sotiropoulou","year":"2009","journal-title":"Biol Chem"},{"key":"30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molonc.2013.09.003","article-title":"Secretome and degradome profiling shows that kallikrein-related peptidases 4, 5, 6, and 7 induce TGF\u03b2-1 signaling in ovarian cancer cells","volume":"8","author":"Schilling","year":"2014","journal-title":"Mol Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/ncomms3575","article-title":"Structural and functional characterization of two alpha-synuclein strains","volume":"4","author":"Melki","year":"2013","journal-title":"Nat Commun"},{"key":"32","first-page":"340","article-title":"\u03b1-synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"18","author":"Baekelandt","year":"2015","journal-title":"Nature"},{"key":"33","first-page":"51","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Lee","year":"2011","journal-title":"Neuron"},{"key":"34","doi-asserted-by":"crossref","first-page":"32989","DOI":"10.1074\/jbc.R109.027946","article-title":"Functional roles of human kallikrein-related peptidases","volume":"284","author":"Diamandis","year":"2009","journal-title":"J Biol Chem"},{"key":"35","doi-asserted-by":"crossref","first-page":"24562","DOI":"10.1074\/jbc.M202392200","article-title":"Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system","volume":"277","author":"Blaber","year":"2002","journal-title":"J Biol Chem"},{"key":"36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0006-291X(03)01271-3","article-title":"Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors","volume":"307","author":"Diamandis","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"37","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","article-title":"Calpain-cleavage of \u03b1-synuclein: connecting proteolytic processing to disease-linked aggregation","volume":"170","author":"Rohn","year":"2007","journal-title":"Am J Pathol"},{"key":"38","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/bi800699v","article-title":"Cathepsin D is the main lysosomal enzyme involved in the degradation of \u03b1-synuclein and generation of its C-terminally truncated species","volume":"47","author":"Yen","year":"2008","journal-title":"Biochemistry"},{"key":"39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.compbiolchem.2007.11.002","article-title":"Identification and analysis of mammalian KLK6 orthologue genes for prediction of physiological substrates","volume":"32","author":"Sotiropoulou","year":"2008","journal-title":"Comput Biol Chem"},{"key":"40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1326-6-72","article-title":"Dopamine and \u03b1-synuclein dysfunction in Smad3 null mice","volume":"6","author":"S\u00e1nchez-Capelo","year":"2011","journal-title":"Mol Neurodegener"},{"key":"41","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Halliday","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-015-0043-6","article-title":"A brain-targeted, modified neurosin (kallikrein-6) reduces \u03b1-synuclein accumulation in a mouse model of multiple system atrophy","volume":"10","author":"Masliah","year":"2015","journal-title":"Mol Neurodegener"},{"key":"43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jnc.12293","article-title":"Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity","volume":"127","author":"Scarisbrick","year":"2013","journal-title":"J Neurochem"},{"key":"44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1752-153X-6-148","article-title":"Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6","volume":"6","author":"Livaniou","year":"2012","journal-title":"Chem Cent J"},{"key":"45","doi-asserted-by":"crossref","first-page":"23542","DOI":"10.1074\/jbc.M801992200","article-title":"Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells","volume":"283","author":"Stefanis","year":"2008","journal-title":"J Biol Chem"},{"key":"46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molonc.2015.08.001","article-title":"Fibroblast activation protein-\u03b1, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations","volume":"10","author":"Schilling","year":"2016","journal-title":"Mol Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T12:27:56Z","timestamp":1589113676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,10]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,2,28]]}},"alternative-id":["13264","27845893"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13264","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,10]]}}}